{"text": ["Lilly's", "Elanco", "animal", "health", "unit's", "IPO", "priced", "at", "$24/share"], "created_at": "2018-09-19 21:38:54"}
{"text": ["Elanco", "Animal", "Health", "prices", "IPO", "above", "expected", "range"], "created_at": "2018-09-19 21:31:00"}
{"text": ["Elanco", "Announces", "Pricing", "of", "Initial", "Public", "Offering"], "created_at": "2018-09-19 21:12:00"}
{"text": ["J&J", "Files", "NDA", "for", "Erdafitinib", "in", "Urothelial", "Cancer", "Indication"], "created_at": "2018-09-19 16:46:34"}
{"text": ["J&J", "Files", "NDA", "for", "Erdafitinib", "in", "Urothelial", "Cancer", "Indication"], "created_at": "2018-09-19 16:46:34"}
{"text": ["Lilly's", "Elanco", "Rises", "After", "$1.5", "Billion", "Animal-Health", "IPO"], "created_at": "2018-09-19 16:01:22"}
{"text": ["Lilly's", "Elanco", "Raises", "$1.5", "Billion", "in", "Animal-Health", "IPO"], "created_at": "2018-09-19 16:01:22"}
{"text": ["J&J", "Files", "NDA", "for", "Erdafitinib", "in", "Urothelial", "Cancer", "Indication"], "created_at": "2018-09-19 15:05:03"}
{"text": ["Pharma", "Stocks:", "Pfizer\u2019s", "Revenue", "Trend", "and", "2018", "Estimates"], "created_at": "2018-09-19 14:30:18"}
{"text": ["Novo", "Nordisk", "to", "Restructure", "R&D", "Unit", "&", "Lay", "Off", "400", "Staff"], "created_at": "2018-09-19 13:38:02"}
{"text": ["Novo", "Nordisk", "to", "Restructure", "R&D", "Unit", "&", "Lay", "Off", "400", "Staff"], "created_at": "2018-09-19 13:38:02"}
{"text": ["Novo", "Nordisk", "to", "Restructure", "R&D", "Unit", "&", "Lay", "Off", "400", "Staff"], "created_at": "2018-09-19 12:48:12"}
{"text": ["Pharma", "Stocks", "in", "Review:", "A", "Valuation", "Comparison"], "created_at": "2018-09-19 11:31:05"}
